Literature DB >> 11154605

Severe osteogenesis imperfecta: new therapeutic options?

R Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11154605      PMCID： PMC1119372     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Bisphosphonates: from the laboratory to the clinic and back again.

Authors:  R G Russell; M J Rogers
Journal:  Bone       Date:  1999-07       Impact factor: 4.398

2.  Osteogenesis imperfecta calls for caution.

Authors:  N J Bishop
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

3.  Osteogenesis imperfecta calls for caution.

Authors:  J C Marini
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

4.  Mesenchymal stem cells: no longer second class marrow citizens.

Authors:  S L Gerson
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

Review 5.  Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis.

Authors:  C Brumsen; N A Hamdy; S E Papapoulos
Journal:  Medicine (Baltimore)       Date:  1997-07       Impact factor: 1.889

6.  Osteogenesis imperfecta--managing brittle bones.

Authors:  J C Marini
Journal:  N Engl J Med       Date:  1998-10-01       Impact factor: 91.245

7.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Authors:  E M Horwitz; D J Prockop; L A Fitzpatrick; W W Koo; P L Gordon; M Neel; M Sussman; P Orchard; J C Marx; R E Pyeritz; M K Brenner
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

8.  Intravenous pamidronate treatment in osteogenesis imperfecta.

Authors:  B Bembi; A Parma; M Bottega; S Ceschel; M Zanatta; C Martini; G Ciana
Journal:  J Pediatr       Date:  1997-10       Impact factor: 4.406

9.  Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta.

Authors:  R F Pereira; M D O'Hara; A V Laptev; K W Halford; M D Pollard; R Class; D Simon; K Livezey; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

10.  Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.

Authors:  F H Glorieux; N J Bishop; H Plotkin; G Chabot; G Lanoue; R Travers
Journal:  N Engl J Med       Date:  1998-10-01       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.